EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY 4.0

Clinical and laboratory characteristics during a 1‐year follow‐up in European Lyme neuroborreliosis: A prospective cohort study

Anne Marit Solheim iD, Ingerid Skarstein, Hanne Quarsten, Åslaug Rudjord Lorentzen, Pål Berg-Hansen, Randi Eikeland, Harald Reiso, Åse Mygland, Unn Ljøstad

European Journal of Neurology · 2024

DOI: 10.1111/ene.16487 ↗

At a glance

Kohortenstudie in European Journal of Neurology, 2024. Written by Anne Marit Solheim and 8 co-authors. Institution: Department of Neurology, Sorlandet Hospital, Kristiansand, Norway. Major MEDLINE topics: Lyme Neuroborreliosis, Chemokine CXCL13. Cited 9 times so far (Crossref); 27 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose We need more knowledge on clinical presentations, time course, biomarkers, and prognosis in European Lyme neuroborreliosis (LNB).

Methods

A prospective 12‐month follow‐up of predetermined clinical and laboratory parameters was undertaken in 105 patients with LNB.

Results

At presentation, 79% had radiculopathy, 49% had facial palsy, and 13% had solely subjective symptoms (predominately pain). Intrathecally produced Borrelia burgdorferi ( Bb ) antibodies were demonstrated and cerebrospinal fluid (CSF) CXCL13 was positive in 85% and 82% pretreatment, in 73% and 10% at 6 months, and in 58% and 14% at 12 months, respectively. CSF Bb polymerase chain reaction (PCR) was positive in 40% pretreatment. In four patients who tested negative for Bb antibodies in both serum and CSF, the diagnosis was supported by typical clinical features, pleocytosis, CSF Bb ‐PCR ( n = 1), or CSF CXCL13 ( n = 2). The proportion with symptoms influencing daily life was 91% pretreatment, 25% at 10 weeks, 20% at 6 months, and 15% at 12 months. Fatigue was the most common complaint at 12 months. A high burden of symptoms before and after treatment was associated with residual complaints at 12 months, whereas background data, other clinical features, and laboratory features were not.

Conclusions

LNB can present with solely subjective symptoms, especially pain. Many LNB patients have persistent Bb antibodies in serum and CSF. In seronegative LNB, CSF Bb‐ PCR and CXCL13 may give diagnostic support. CXCL13 may be persistently positive after treatment in some patients. Most of the clinical improvement occurs during the first 10 weeks. High initial clinical score is associated with poorer outcome.

Subjects

MeSH terms (MEDLINE)

Lyme NeuroborreliosisChemokine CXCL13HumansMaleFemaleMiddle AgedAdultAgedProspective StudiesFollow-Up StudiesBorrelia burgdorferiEuropeAntibodies, BacterialAdolescentYoung AdultCohort StudiesBiomarkersAged, 80 and overRadiculopathy

Author keywords

biomarkerscase definitionclinical characteristicsneuroborreliosisprognosis

Substances

Chemokine CXCL13CXCL13 protein, humanAntibodies, BacterialBiomarkers

Authors and institutions

  • Department of Neurology, Sorlandet Hospital, Kristiansand, Norway.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Department of Microbiology, Sorlandet Hospital, Kristiansand, Norway.
  • Norwegian National Advisory Unit on Tick-Borne Diseases, Sorlandet Hospital, Kristiansand, Norway.

ORCID profiles: Anne Marit Solheim

Cite

APA

Solheim, A. M., Skarstein, I., Quarsten, H., Lorentzen, Å. R., Berg-Hansen, P., Eikeland, R., Reiso, H., Mygland, Å., & Ljøstad, U. (2024). Clinical and laboratory characteristics during a 1‐year follow‐up in European Lyme neuroborreliosis: A prospective cohort study. European Journal of Neurology. https://doi.org/10.1111/ene.16487

Vancouver

Solheim AM, Skarstein I, Quarsten H, Lorentzen ÅR, Berg-Hansen P, Eikeland R, et al. Clinical and laboratory characteristics during a 1‐year follow‐up in European Lyme neuroborreliosis: A prospective cohort study. European Journal of Neurology. 2024. doi:10.1111/ene.16487

BibTeX
@article{Solheim2024,
  author = {Solheim, Anne Marit and Skarstein, Ingerid and Quarsten, Hanne and Lorentzen, Åslaug Rudjord and Berg-Hansen, Pål and Eikeland, Randi and Reiso, Harald and Mygland, Åse and Ljøstad, Unn},
  title = {Clinical and laboratory characteristics during a 1‐year follow‐up in European Lyme neuroborreliosis: A prospective cohort study},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16487}
}
Start for free →